Senator Tommy Tuberville of Alabama has emerged as the most active equity trader in the U.S. Senate, engaging in numerous stock transactions, as revealed by an analysis of his financial disclosures.
His trading activities have raised concerns among several government watchdog groups.
Tuberville has often stated that he does not personally manage the day-to-day trading, insisting that his brokers handle the portfolio.
As a senator, he has access to non-public information and significant influence over policies that can affect the stock market.
Here are four stocks and products from Tuberville’s trading portfolio:
Apple
Earlier this year, Tuberville’s Apple trades gained attention, especially when President Donald Trump ramped up his tariff rhetoric, which led to what some considered “super suspicious” trades, according to Financial News Outlet Finbold.
On January 1st, he sold shares of both Microsoft and Apple, valued between $15,001 and $50,000.
This sale occurred just before a significant downturn in the tech sector, with Apple shares dropping nearly 30% by early April, resulting in a loss of approximately $300 billion in market value as Trump’s tariff threats became more pronounced. The tech industry, heavily reliant on manufacturing and trade with China, found itself amid turbulent conditions.
In early April, Tuberville criticized Wall Street for the market decline while simultaneously supporting Trump’s tariffs, even though he had divested some shares a few months before.
Microsoft
Microsoft holds a contract with the Department of Defense, and Tuberville is part of the Senate Armed Services Committee.
In 2021, Tuberville and his wife reported capital gains between $15,003 and $45,000 from their Microsoft stock options.
On June 23, 2021, they sold stock options for Microsoft worth between $1,001 and $15,000, just 13 days before Microsoft lost a $10 billion cloud computing contract with the Department of Defense.
Commodities
As a member of the Senate Agriculture Committee, Tuberville was involved in discussions surrounding potential legislation that could impact cattle prices.
He also sits on the Subcommittee on Commodities, Derivatives, Risk Management, and Trade, which oversees programs related to commodities, including crop insurance and agricultural trade.
His trading includes several futures in commodities such as corn, beef, and wheat. Tuberville asserts that the committee has never shared sensitive information with brokers.
In his 2021 financial disclosure, he reported earning between $98,421 and $237,200 from commodity transactions.
Humacyte
Humacyte is a biotech firm recognized for assisting injured Ukrainian soldiers since May 2022.
On July 25, 2023, Tuberville made three purchases of Humacyte stocks amounting to between $3,003 and $45,000.
At the time, the stock was close to a record low of $2.87 per share. Shortly after, the company reported on advancements in using exchange vascular technology in treating traumatic injuries among Ukrainian soldiers.
Interestingly, Tuberville is involved in two committees that overlap with Humacyte’s area of work: armed services and health, education, labor, and pensions.
On April 30, 2024, he sold stocks valued between $50,001 and $100,000, only to acquire additional shares worth between $16,002 and $65,000 a few days later. This sale reflected a closing price of $4.4 per share, resulting in a more than 53% return.
